SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001650664-24-000078
Filing Date
2024-06-14
Accepted
2024-06-14 06:04:37
Documents
16
Period of Report
2024-06-14
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K edit-20240614.htm   iXBRL 8-K 35994
2 EX-99.1 ex991.htm EX-99.1 30261
3 EX-99.2 ex992.htm EX-99.2 29072
7 image_0.jpg GRAPHIC 10702
  Complete submission text file 0001650664-24-000078.txt   250903

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT edit-20240614.xsd EX-101.SCH 1994
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT edit-20240614_lab.xml EX-101.LAB 21885
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT edit-20240614_pre.xml EX-101.PRE 12591
19 EXTRACTED XBRL INSTANCE DOCUMENT edit-20240614_htm.xml XML 2714
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 241043009
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)